Retour

Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results

Calendar Calendar of Events

BERKELEY HEIGHTS, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce first quarter 2024 financial results on Tuesday, May 14, 2024. The Company will host a conference call and live webcast at 4:30 p.m. Eastern Daylight Time on the same day.

GlobeNewswire Inc. • 08/05/2024 à 15:15:00
Cyclacel Pharmaceuticals, Inc
Address: 200 CONNELL DRIVE
Postal Code: 07922
City: BERKELEY HEIGHTS
State: NJ
Phone Number: 908-517-7330
Website: https://cyclacel.com
Status: Active
Company Info

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

List Date2006-03-28
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001130166
Composite figiBBG000CT3XM2
Share Class figiBBG001SGNL18
Market Cap3,350,863 USD
SIC Code2834
SIC DescriptionPHARMACEUTICAL PREPARATIONS
Total Employees12
Share Class Shares Outstanding1460000
Weighted Shares Outstanding1463259
Round Lot100
Updated date2024-05-19
Stats
Last 5 days
17-05
16-05
15-05
14-05
13-05
Last
2.31
2.36
2.495
2.63
2.76
Variance
-2.33%
-4.95%
-12.15%
-4.36%
20.1%
Open
2.365
2.483
2.84
2.75
2.298
Highest
2.425
2.525
2.84
2.825
2.955
Lowest
2.425
2.515
2.84
2.815
2.857
History
PeriodVarhighestlowest
1 week
0.52%
2.955
2.425
1 month
29.41%
1.895
1.58
3 month
-18.95%
3.05
1.58
6 month
-50.32%
4.695
1.58
1 year
-75.16%
9.7913
1.58
3 year
-97.96%
116.25
1.58
5 year
-98.85%
216
1.58
10 year
-99.98%
11620.8
1.58
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-10 2023-11-29 UNPUB
Assets 22,060,000 16,442,000 12,497,000 UNPUB
Current Assets 18,974,000 15,294,000 11,113,000 UNPUB
Current Liabilities 7,338,000 6,746,000 8,148,000 UNPUB
Equity 10,148,000 5,136,000 4,297,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 10,148,000 5,136,000 4,297,000 UNPUB
Liabilities 7,418,000 6,812,000 8,200,000 UNPUB
Liabilities And Equity 22,060,000 16,442,000 12,497,000 UNPUB
Noncurrent Assets 3,086,000 1,148,000 1,384,000 UNPUB
Noncurrent Liabilities 80,000 66,000 52,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-10 2023-11-29 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -6,917,000 -1,356,000 -4,086,000 UNPUB
Net Cash Flow, Continuing -6,917,000 -1,356,000 -4,086,000 UNPUB
Net Cash Flow From Financing Activities -50,000 -51,000 -50,000 UNPUB
Net Cash Flow From Financing Activities, Continuing -50,000 -51,000 -50,000 UNPUB
Net Cash Flow From Investing Activities -6,000 0 0 UNPUB
Net Cash Flow From Investing Activities, Continuing -6,000 0 0 UNPUB
Net Cash Flow From Operating Activities -6,861,000 -1,305,000 -4,036,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -6,861,000 -1,305,000 -4,036,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-10 2023-11-29 UNPUB
Comprehensive Income/Loss -5,712,000 -5,321,000 -6,103,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -5,712,000 -5,321,000 -6,103,000 UNPUB
Other Comprehensive Income/Loss -5,712,000 -5,321,000 -6,103,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-10 2023-11-29 UNPUB
Basic Earnings Per Share 0 0 UNPUB UNPUB
Benefits Costs and Expenses UNPUB 6,407,000 6,716,000 UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB 6,407,000 6,716,000 UNPUB
Diluted Earnings Per Share 0 0 UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -5,804,000 -5,448,000 -6,032,000 UNPUB
Income/Loss From Continuing Operations Before Tax -7,124,000 -6,034,000 -6,700,000 UNPUB
Income Tax Expense/Benefit -1,320,000 -586,000 -668,000 UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -5,804,000 -5,448,000 -6,032,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -5,804,000 -5,448,000 -6,032,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -5,804,000 -5,448,000 -6,032,000 UNPUB
Operating Expenses 7,319,000 6,302,000 6,861,000 UNPUB
Operating Income/Loss -7,319,000 -5,929,000 -6,845,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 0 373,000 16,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-10 2023-03-08
Assets 39,629,000 35,346,000 31,021,000 27,501,000
Current Assets 36,577,000 32,077,000 27,915,000 24,411,000
Current Liabilities 6,204,000 5,026,000 4,353,000 7,392,000
Equity 33,410,000 30,207,000 22,067,000 15,509,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 33,410,000 30,207,000 22,067,000 15,509,000
Liabilities 6,219,000 5,139,000 4,460,000 7,498,000
Liabilities And Equity 39,629,000 35,346,000 31,021,000 27,501,000
Noncurrent Assets 3,052,000 3,269,000 3,106,000 3,090,000
Noncurrent Liabilities 0 0 107,000 106,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-10 2023-03-08
Exchange Gains/Losses -91,000 -118,000 UNPUB UNPUB
Net Cash Flow -6,920,000 -562,000 -5,227,000 -17,836,000
Net Cash Flow, Continuing -6,829,000 -444,000 -5,436,000 -17,836,000
Net Cash Flow From Financing Activities -50,000 1,474,000 1,532,000 2,998,000
Net Cash Flow From Financing Activities, Continuing -50,000 1,474,000 1,532,000 2,998,000
Net Cash Flow From Investing Activities -4,000 -3,000 0 -7,000
Net Cash Flow From Investing Activities, Continuing -4,000 -3,000 0 -7,000
Net Cash Flow From Operating Activities -6,775,000 -1,915,000 -6,968,000 -20,827,000
Net Cash Flow From Operating Activities, Continuing -6,775,000 -1,915,000 -6,968,000 -20,827,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-10 2023-03-08
Comprehensive Income/Loss -4,108,000 -4,575,000 -5,566,000 -21,766,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -4,183,000 -5,028,000 -5,566,000 -21,766,000
Other Comprehensive Income/Loss 0 0 -5,566,000 -21,766,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-10 2023-03-08
Basic Earnings Per Share 0 0 0 -2
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB 27,656,000
Diluted Earnings Per Share 0 0 0 -2
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -4,108,000 -4,575,000 -5,096,000 -21,198,000
Income/Loss From Continuing Operations Before Tax -5,246,000 -5,559,000 -6,110,000 -25,915,000
Income Tax Expense/Benefit -1,138,000 -984,000 -1,014,000 -4,717,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -4,108,000 -4,575,000 -5,096,000 -21,198,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -4,108,000 -4,575,000 -5,096,000 -21,198,000
Net Income/Loss Available To Common Stockholders, Basic -4,108,000 -4,575,000 -5,096,000 -21,198,000
Operating Expenses 6,559,000 5,785,000 6,467,000 UNPUB
Operating Income/Loss -6,559,000 -5,785,000 -6,467,000 -27,656,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-14 2021-08-12 2021-11-12 2022-03-30
Assets 51,817,000 46,334,000 44,999,000 42,587,000
Current Assets 50,463,000 46,203,000 43,375,000 40,942,000
Current Liabilities 2,772,000 3,118,000 3,591,000 5,294,000
Equity 48,048,000 43,222,000 41,364,000 37,263,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 48,048,000 43,222,000 41,364,000 37,263,000
Liabilities 3,768,000 3,118,000 3,635,000 5,324,000
Liabilities And Equity 51,817,000 46,334,000 44,999,000 42,587,000
Noncurrent Assets 1,354,000 131,000 1,624,000 1,645,000
Noncurrent Liabilities 0 0 44,000 30,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-14 2021-08-12 2021-11-12 2022-03-30
Exchange Gains/Losses 18,000 66,000 -105,000 -17,000
Net Cash Flow 14,371,000 -4,138,000 -3,420,000 3,153,000
Net Cash Flow, Continuing 14,353,000 -4,204,000 -3,315,000 3,170,000
Net Cash Flow From Financing Activities 17,997,000 -51,000 2,904,000 21,737,000
Net Cash Flow From Financing Activities, Continuing 17,997,000 -51,000 2,904,000 21,737,000
Net Cash Flow From Investing Activities -78,000 62,000 -9,000 -27,000
Net Cash Flow From Investing Activities, Continuing -78,000 62,000 -9,000 -27,000
Net Cash Flow From Operating Activities -3,566,000 -4,215,000 -6,210,000 -18,540,000
Net Cash Flow From Operating Activities, Continuing -3,566,000 -4,215,000 -6,210,000 -18,540,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-14 2021-08-12 2021-11-12 2022-03-30
Comprehensive Income/Loss -3,478,000 -5,127,000 -5,082,000 -18,889,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -3,462,000 -5,055,000 -5,082,000 -18,889,000
Other Comprehensive Income/Loss 0 0 -5,082,000 -18,889,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-14 2021-08-12 2021-11-12 2022-03-30
Basic Earnings Per Share UNPUB UNPUB UNPUB -2
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 4,305,000 6,100,000 5,998,000 22,938,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB -2
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -3,478,000 -5,127,000 -4,987,000 -18,887,000
Income/Loss From Continuing Operations Before Tax -4,165,000 -6,091,000 -5,985,000 -22,734,000
Income Tax Expense/Benefit -687,000 -964,000 -998,000 -3,847,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -3,478,000 -5,127,000 -4,987,000 -18,887,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -3,478,000 -5,127,000 -4,987,000 -18,887,000
Net Income/Loss Available To Common Stockholders, Basic -3,478,000 -5,127,000 -4,987,000 -18,887,000
Operating Expenses UNPUB UNPUB UNPUB UNPUB
Operating Income/Loss -4,305,000 -6,100,000 -5,998,000 -22,938,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-12 2020-08-13 2020-11-12 2021-03-01
Assets 12,987,000 29,171,000 27,213,000 36,802,000
Current Assets 11,811,000 27,933,000 25,934,000 35,469,000
Current Liabilities 1,523,000 1,512,000 1,712,000 2,486,000
Equity 10,390,000 26,578,000 24,438,000 33,259,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 10,390,000 26,578,000 24,438,000 33,259,000
Liabilities 2,596,000 2,593,000 2,775,000 3,543,000
Liabilities And Equity 12,987,000 29,171,000 27,213,000 36,802,000
Noncurrent Assets 1,176,000 1,238,000 1,279,000 1,333,000
Noncurrent Liabilities 0 0 1,063,000 1,057,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-12 2020-08-13 2020-11-12 2021-03-01
Exchange Gains/Losses -101,000 9,000 17,000 47,000
Net Cash Flow -2,962,000 16,419,000 -2,212,000 21,521,000
Net Cash Flow, Continuing -2,861,000 16,410,000 -2,229,000 21,474,000
Net Cash Flow From Financing Activities -50,000 18,256,000 -50,000 29,504,000
Net Cash Flow From Financing Activities, Continuing -50,000 18,256,000 -50,000 29,504,000
Net Cash Flow From Investing Activities -4,000 0 -50,000 -96,000
Net Cash Flow From Investing Activities, Continuing -4,000 0 -50,000 -96,000
Net Cash Flow From Operating Activities -2,807,000 -1,846,000 -2,129,000 -7,934,000
Net Cash Flow From Operating Activities, Continuing -2,807,000 -1,846,000 -2,129,000 -7,934,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-12 2020-08-13 2020-11-12 2021-03-01
Comprehensive Income/Loss -1,220,000 -2,166,000 -2,203,000 -8,372,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -1,347,000 -2,154,000 -2,203,000 -8,372,000
Other Comprehensive Income/Loss 0 0 -2,203,000 -8,372,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-12 2020-08-13 2020-11-12 2021-03-01
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 2,424,000 2,472,000 2,572,000 10,636,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -1,220,000 -2,166,000 -2,256,000 -8,445,000
Income/Loss From Continuing Operations Before Tax -1,510,000 -2,452,000 -2,537,000 -9,681,000
Income Tax Expense/Benefit -290,000 -286,000 -281,000 -1,236,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -1,220,000 -2,166,000 -2,256,000 -8,445,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -1,220,000 -2,166,000 -2,256,000 -8,445,000
Net Income/Loss Available To Common Stockholders, Basic -1,220,000 -2,166,000 -2,256,000 -8,445,000
Operating Expenses UNPUB UNPUB UNPUB UNPUB
Operating Income/Loss -2,424,000 -2,472,000 -2,572,000 -10,636,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-14 2019-08-13 2019-11-13 2020-03-05
Assets 21,510,000 19,464,000 17,077,000 15,308,000
Current Assets 20,124,000 18,150,000 15,836,000 14,017,000
Current Liabilities 2,487,000 2,500,000 2,071,000 2,420,000
Equity 17,555,000 15,731,000 13,852,000 11,697,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 17,555,000 15,731,000 13,852,000 11,697,000
Liabilities 3,955,000 3,733,000 3,225,000 3,611,000
Liabilities And Equity 21,510,000 19,464,000 17,077,000 15,308,000
Noncurrent Assets 1,386,000 1,314,000 1,241,000 1,291,000
Noncurrent Liabilities 0 0 1,154,000 1,191,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-14 2019-08-13 2019-11-13 2020-03-05
Exchange Gains/Losses 31,000 -38,000 -119,000 -48,000
Net Cash Flow 430,000 -2,775,000 -2,191,000 -5,619,000
Net Cash Flow, Continuing 399,000 -2,737,000 -2,072,000 -5,571,000
Net Cash Flow From Financing Activities 4,056,000 -101,000 -57,000 3,848,000
Net Cash Flow From Financing Activities, Continuing 4,056,000 -101,000 -57,000 3,848,000
Net Cash Flow From Investing Activities 27,000 -1,000 -4,000 28,000
Net Cash Flow From Investing Activities, Continuing 27,000 -1,000 -4,000 28,000
Net Cash Flow From Operating Activities -3,684,000 -2,635,000 -2,011,000 -9,447,000
Net Cash Flow From Operating Activities, Continuing -3,684,000 -2,635,000 -2,011,000 -9,447,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-14 2019-08-13 2019-11-13 2020-03-05
Comprehensive Income/Loss -1,842,000 -1,783,000 -2,007,000 -7,889,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -1,863,000 -1,810,000 -2,007,000 -7,889,000
Other Comprehensive Income/Loss 0 0 -2,007,000 -7,889,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-14 2019-08-13 2019-11-13 2020-03-05
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB 2,348,000 9,682,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -1,842,000 -1,783,000 -1,901,000 -7,830,000
Income/Loss From Continuing Operations Before Tax -2,110,000 -2,090,000 -2,174,000 -9,126,000
Income Tax Expense/Benefit -268,000 -307,000 -273,000 -1,296,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -1,842,000 -1,783,000 -1,901,000 -7,830,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -1,842,000 -1,783,000 -1,901,000 -7,830,000
Net Income/Loss Available To Common Stockholders, Basic -1,842,000 -1,783,000 -1,901,000 -7,830,000
Operating Expenses 2,204,000 2,337,000 UNPUB UNPUB
Operating Income/Loss -2,204,000 -2,337,000 -2,348,000 -9,682,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 50,000 50,000 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-14 2018-08-09 2018-11-13 2019-03-28
Assets 24,777,000 22,730,000 20,707,000 19,823,000
Current Assets 24,732,000 22,687,000 20,669,000 19,787,000
Current Liabilities 4,258,000 3,994,000 4,003,000 4,451,000
Equity 20,395,000 18,624,000 16,598,000 15,272,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 20,395,000 18,624,000 16,598,000 15,272,000
Liabilities 4,382,000 4,106,000 4,109,000 4,551,000
Liabilities And Equity 24,777,000 22,730,000 20,707,000 19,823,000
Noncurrent Assets 45,000 43,000 38,000 36,000
Noncurrent Liabilities 124,000 112,000 106,000 100,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-14 2018-08-09 2018-11-13 2019-03-28
Exchange Gains/Losses 26,000 -14,000 -100,000 -95,000
Net Cash Flow -2,185,000 -1,901,000 -851,000 -6,406,000
Net Cash Flow, Continuing -2,211,000 -1,887,000 -751,000 -6,311,000
Net Cash Flow From Financing Activities -50,000 -51,000 -50,000 429,000
Net Cash Flow From Financing Activities, Continuing -50,000 -51,000 -50,000 429,000
Net Cash Flow From Investing Activities -22,000 -9,000 -2,000 -39,000
Net Cash Flow From Investing Activities, Continuing -22,000 -9,000 -2,000 -39,000
Net Cash Flow From Operating Activities -2,139,000 -1,803,000 -723,000 -6,701,000
Net Cash Flow From Operating Activities, Continuing -2,139,000 -1,803,000 -723,000 -6,701,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-14 2018-08-09 2018-11-13 2019-03-28
Comprehensive Income/Loss -1,401,000 -1,805,000 -2,066,000 -7,254,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -1,401,000 -1,805,000 -2,066,000 -7,254,000
Other Comprehensive Income/Loss -1,401,000 -1,805,000 -2,066,000 -7,254,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-14 2018-08-09 2018-11-13 2019-03-28
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB 8,775,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB 8,775,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -1,349,000 -1,852,000 -2,068,000 -7,288,000
Income/Loss From Continuing Operations Before Tax -1,531,000 -2,354,000 -2,369,000 -8,625,000
Income Tax Expense/Benefit -182,000 -502,000 -301,000 -1,337,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -1,349,000 -1,852,000 -2,068,000 -7,288,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -1,349,000 -1,852,000 -2,068,000 -7,288,000
Net Income/Loss Available To Common Stockholders, Basic -1,399,000 -1,902,000 -2,118,000 -7,288,000
Operating Expenses 2,162,000 2,465,000 2,455,000 9,698,000
Operating Income/Loss -2,162,000 -2,465,000 -2,455,000 -9,548,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 50,000 50,000 50,000 0
Preferred Stock Dividends And Other Adjustments 50,000 50,000 50,000 0
Revenues 0 0 0 150,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-12 2017-08-10 2017-11-13 2018-03-30
Assets 17,073,000 16,083,000 27,851,000 26,003,000
Current Assets 17,034,000 16,051,000 27,817,000 25,974,000
Current Liabilities 4,128,000 4,319,000 4,265,000 4,113,000
Equity 12,818,000 11,636,000 23,458,000 21,766,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 12,818,000 11,636,000 23,458,000 21,766,000
Liabilities 4,255,000 4,447,000 4,393,000 4,237,000
Liabilities And Equity 17,073,000 16,083,000 27,851,000 26,003,000
Noncurrent Assets 39,000 32,000 34,000 29,000
Noncurrent Liabilities 127,000 128,000 128,000 124,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-12 2017-08-10 2017-11-13 2018-03-30
Exchange Gains/Losses -15,000 137,000 54,000 135,000
Net Cash Flow -3,791,000 862,000 12,434,000 7,390,000
Net Cash Flow, Continuing -3,776,000 725,000 12,380,000 7,255,000
Net Cash Flow From Financing Activities 36,000 926,000 13,638,000 14,748,000
Net Cash Flow From Financing Activities, Continuing 36,000 926,000 13,638,000 14,748,000
Net Cash Flow From Investing Activities -2,000 0 -9,000 -13,000
Net Cash Flow From Investing Activities, Continuing -2,000 0 -9,000 -13,000
Net Cash Flow From Operating Activities -3,810,000 -201,000 -1,249,000 -7,480,000
Net Cash Flow From Operating Activities, Continuing -3,810,000 -201,000 -1,249,000 -7,480,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-12 2017-08-10 2017-11-13 2018-03-30
Comprehensive Income/Loss -1,560,000 -2,174,000 -1,883,000 -7,521,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -1,560,000 -2,174,000 -1,883,000 -7,521,000
Other Comprehensive Income/Loss -1,560,000 -2,174,000 -1,883,000 -7,521,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-12 2017-08-10 2017-11-13 2018-03-30
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB 9,491,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -1,555,000 -2,187,000 -1,857,000 -7,470,000
Income/Loss From Continuing Operations Before Tax -1,861,000 -2,455,000 -2,076,000 -8,463,000
Income Tax Expense/Benefit -306,000 -268,000 -219,000 -993,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -1,555,000 -2,187,000 -1,857,000 -7,470,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -1,555,000 -2,187,000 -1,857,000 -7,470,000
Net Income/Loss Available To Common Stockholders, Basic -1,605,000 -2,237,000 -1,907,000 -7,671,000
Operating Expenses 2,693,000 2,489,000 2,112,000 UNPUB
Operating Income/Loss -2,693,000 -2,489,000 -2,112,000 -9,491,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 50,000 50,000 50,000 201,000
Preferred Stock Dividends And Other Adjustments 50,000 50,000 50,000 201,000
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-13 2016-08-11 2016-11-14 2017-03-31
Assets 21,461,000 18,877,000 22,652,000 19,662,000
Current Assets 21,310,000 18,768,000 22,579,000 19,617,000
Current Liabilities 5,396,000 5,565,000 5,570,000 5,259,000
Equity 15,899,000 13,162,000 16,941,000 14,273,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 15,899,000 13,162,000 16,941,000 14,273,000
Liabilities 5,562,000 5,715,000 5,711,000 5,389,000
Liabilities And Equity 21,461,000 18,877,000 22,652,000 19,662,000
Noncurrent Assets 151,000 109,000 73,000 45,000
Noncurrent Liabilities 166,000 150,000 141,000 130,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-13 2016-08-11 2016-11-14 2017-03-31
Exchange Gains/Losses -128,000 -252,000 14,000 -444,000
Net Cash Flow -3,325,000 -1,184,000 2,098,000 -3,920,000
Net Cash Flow, Continuing -3,197,000 -932,000 2,084,000 -3,476,000
Net Cash Flow From Financing Activities -50,000 104,000 5,037,000 6,594,000
Net Cash Flow From Financing Activities, Continuing -50,000 104,000 5,037,000 6,594,000
Net Cash Flow From Investing Activities -128,000 -252,000 14,000 9,000
Net Cash Flow From Investing Activities, Continuing -128,000 -252,000 14,000 9,000
Net Cash Flow From Operating Activities -3,147,000 -1,036,000 -2,953,000 -10,079,000
Net Cash Flow From Operating Activities, Continuing -3,147,000 -1,036,000 -2,953,000 -10,079,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-13 2016-08-11 2016-11-14 2017-03-31
Comprehensive Income/Loss -3,041,000 -3,040,000 -2,967,000 -11,791,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -3,041,000 -3,040,000 -2,967,000 -11,791,000
Other Comprehensive Income/Loss 0 -3,040,000 -2,967,000 0
Other Comprehensive Income/Loss Attributable To Parent -3,107,000 UNPUB UNPUB -11,938,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-13 2016-08-11 2016-11-14 2017-03-31
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 3,673,000 3,813,000 3,605,000 14,617,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 3,883,000 3,813,000 3,605,000 14,993,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -3,041,000 -2,965,000 -2,946,000 -11,791,000
Income/Loss From Continuing Operations Before Tax -3,534,000 -3,591,000 -3,400,000 -13,774,000
Income Tax Expense/Benefit -493,000 -626,000 -454,000 -1,983,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -3,041,000 -2,965,000 -2,946,000 -11,791,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -3,041,000 -2,965,000 -2,946,000 -11,791,000
Net Income/Loss Available To Common Stockholders, Basic -3,091,000 -3,015,000 -2,996,000 -11,991,000
Operating Expenses 3,883,000 3,982,000 3,682,000 14,993,000
Operating Income/Loss -3,744,000 -3,760,000 -3,477,000 -14,150,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 50,000 50,000 50,000 200,000
Preferred Stock Dividends And Other Adjustments 50,000 50,000 50,000 200,000
Revenues 139,000 222,000 205,000 843,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-12 2015-08-12 2015-11-12 2016-03-29
Assets 35,357,000 30,788,000 27,049,000 24,764,000
Current Assets 35,024,000 30,479,000 26,794,000 24,566,000
Current Liabilities 8,136,000 6,490,000 5,263,000 5,753,000
Equity 27,029,000 24,100,000 21,600,000 18,835,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 27,029,000 24,100,000 21,600,000 18,835,000
Liabilities 8,328,000 6,688,000 5,449,000 5,929,000
Liabilities And Equity 35,357,000 30,788,000 27,049,000 24,764,000
Noncurrent Assets 333,000 309,000 255,000 198,000
Noncurrent Liabilities 192,000 198,000 186,000 176,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-12 2015-08-12 2015-11-12 2016-03-29
Exchange Gains/Losses -318,000 452,000 -228,000 -211,000
Net Cash Flow 4,856,000 -2,009,000 -4,402,000 -3,749,000
Net Cash Flow, Continuing 5,174,000 -2,461,000 -4,174,000 -3,634,000
Net Cash Flow From Financing Activities 10,383,000 -127,000 170,000 10,860,000
Net Cash Flow From Financing Activities, Continuing 10,383,000 -127,000 170,000 10,860,000
Net Cash Flow From Investing Activities 9,000 -8,000 -10,000 158,000
Net Cash Flow From Investing Activities, Continuing 9,000 -8,000 -10,000 62,000
Net Cash Flow From Operating Activities -4,900,000 -2,778,000 -4,106,000 -14,460,000
Net Cash Flow From Operating Activities, Continuing -4,900,000 -2,778,000 -4,106,000 -14,460,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-12 2015-08-12 2015-11-12 2016-03-29
Comprehensive Income/Loss -4,912,000 -3,347,000 -2,709,000 -14,342,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -4,912,000 -3,347,000 -2,709,000 -14,342,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent -5,123,000 -3,044,000 -2,861,000 -14,458,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-12 2015-08-12 2015-11-12 2016-03-29
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 6,187,000 4,048,000 3,902,000 18,430,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 5,810,000 3,913,000 4,109,000 18,114,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -4,912,000 -3,347,000 -2,709,000 -14,342,000
Income/Loss From Continuing Operations Before Tax -5,675,000 -3,752,000 -3,187,000 -16,486,000
Income Tax Expense/Benefit -763,000 -405,000 -478,000 -2,144,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -4,912,000 -3,347,000 -2,709,000 -14,342,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -4,912,000 -3,347,000 -2,709,000 -14,342,000
Net Income/Loss Available To Common Stockholders, Basic -4,962,000 -3,397,000 -2,759,000 -14,543,000
Operating Expenses 5,810,000 3,913,000 4,109,000 18,114,000
Operating Income/Loss -5,298,000 -3,617,000 -3,394,000 -16,170,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 50,000 50,000 50,000 201,000
Preferred Stock Dividends And Other Adjustments 50,000 50,000 50,000 201,000
Revenues 512,000 296,000 715,000 1,944,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-13 2014-08-12 2014-11-12 2015-03-31
Assets 33,785,000 37,610,000 31,630,000 29,387,000
Current Assets 33,452,000 37,281,000 31,176,000 29,000,000
Current Liabilities 8,810,000 7,783,000 6,766,000 7,493,000
Equity 24,975,000 29,589,000 24,643,000 21,688,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 24,975,000 29,589,000 24,643,000 21,688,000
Liabilities 8,810,000 8,021,000 6,987,000 7,699,000
Liabilities And Equity 33,785,000 37,610,000 31,630,000 29,387,000
Noncurrent Assets 333,000 329,000 454,000 387,000
Noncurrent Liabilities 0 238,000 221,000 206,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-13 2014-08-12 2014-11-12 2015-03-31
Exchange Gains/Losses 43,000 102,000 -351,000 -530,000
Net Cash Flow -2,949,000 5,404,000 -7,100,000 -7,487,000
Net Cash Flow, Continuing -2,992,000 5,302,000 -6,749,000 -6,957,000
Net Cash Flow From Financing Activities 1,626,000 9,239,000 -50,000 12,200,000
Net Cash Flow From Financing Activities, Continuing 1,626,000 9,239,000 -50,000 12,200,000
Net Cash Flow From Investing Activities 65,000 62,000 -141,000 75,000
Net Cash Flow From Investing Activities, Continuing 65,000 62,000 -141,000 75,000
Net Cash Flow From Operating Activities -4,726,000 -4,101,000 -6,207,000 -18,702,000
Net Cash Flow From Operating Activities, Continuing -4,726,000 -4,101,000 -6,207,000 -18,702,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-13 2014-08-12 2014-11-12 2015-03-31
Comprehensive Income/Loss -4,869,000 -4,812,000 -4,907,000 -19,387,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -4,869,000 -4,812,000 -4,907,000 -19,387,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent -4,861,000 -4,808,000 -5,115,000 -19,758,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-13 2014-08-12 2014-11-12 2015-03-31
Basic Earnings Per Share 0 0 UNPUB UNPUB
Benefits Costs and Expenses 5,842,000 5,991,000 6,396,000 24,383,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 5,806,000 5,931,000 6,405,000 24,171,000
Diluted Earnings Per Share 0 0 UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -4,877,000 -4,819,000 -4,911,000 -19,406,000
Income/Loss From Continuing Operations Before Tax -5,446,000 -5,635,000 -5,661,000 -22,649,000
Income Tax Expense/Benefit -569,000 -816,000 -750,000 -3,243,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -4,869,000 -4,812,000 -4,907,000 -19,387,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -4,869,000 -4,812,000 -4,907,000 -19,387,000
Net Income/Loss Available To Common Stockholders, Basic -4,919,000 -4,862,000 -4,957,000 -19,587,000
Operating Expenses 5,806,000 5,931,000 6,405,000 24,171,000
Operating Income/Loss -5,410,000 -5,575,000 -5,670,000 -22,437,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 50,000 50,000 50,000 200,000
Preferred Stock Dividends And Other Adjustments 50,000 50,000 50,000 200,000
Revenues 396,000 356,000 735,000 1,734,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-13 2013-08-14 2013-11-14 2014-03-26
Assets 17,486,000 37,510,000 37,989,000 35,520,000
Current Assets 17,030,000 37,155,000 37,719,000 35,173,000
Current Liabilities 7,252,000 6,579,000 8,978,000 7,497,000
Equity 10,234,000 30,931,000 29,011,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 10,234,000 30,931,000 29,011,000 UNPUB
Liabilities 7,252,000 6,579,000 8,978,000 7,497,000
Liabilities And Equity 17,486,000 37,510,000 37,989,000 35,520,000
Noncurrent Assets 456,000 355,000 270,000 347,000
Noncurrent Liabilities 0 0 0 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-13 2013-08-14 2013-11-14 2014-03-26
Exchange Gains/Losses -230,000 193,000 -113,000 -87,000
Net Cash Flow -2,503,000 19,722,000 706,000 14,647,000
Net Cash Flow, Continuing -2,273,000 19,529,000 819,000 14,734,000
Net Cash Flow From Financing Activities 3,285,000 19,018,000 3,078,000 27,332,000
Net Cash Flow From Financing Activities, Continuing 3,285,000 19,018,000 3,078,000 27,332,000
Net Cash Flow From Investing Activities 40,000 5,632,000 -7,000 5,688,000
Net Cash Flow From Investing Activities, Continuing 40,000 5,632,000 -7,000 5,688,000
Net Cash Flow From Operating Activities -5,368,000 -5,314,000 -2,139,000 -18,199,000
Net Cash Flow From Operating Activities, Continuing -5,368,000 -5,314,000 -2,139,000 -18,199,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-13 2013-08-14 2013-11-14 2014-03-26
Comprehensive Income/Loss -3,082,000 1,492,000 -5,004,000 -10,153,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -3,082,000 1,492,000 -5,004,000 -10,153,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent -3,323,000 1,680,000 -5,171,000 -10,310,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-13 2013-08-14 2013-11-14 2014-03-26
Basic Earnings Per Share -1 0 UNPUB UNPUB
Benefits Costs and Expenses 3,568,000 -984,000 6,055,000 12,964,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 4,263,000 4,418,000 6,104,000 19,058,000
Diluted Earnings Per Share -1 0 UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -3,098,000 1,478,000 -5,016,000 -10,210,000
Income/Loss From Continuing Operations Before Tax -3,356,000 1,248,000 -5,746,000 -11,880,000
Income Tax Expense/Benefit -258,000 -230,000 -730,000 -1,670,000
Interest Expense, Operating UNPUB 0 0 UNPUB
Net Income/Loss -3,082,000 1,492,000 -5,004,000 -10,153,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -3,082,000 1,492,000 -5,004,000 -10,153,000
Net Income/Loss Available To Common Stockholders, Basic -11,570,000 1,429,000 -5,728,000 -19,478,000
Operating Expenses 4,263,000 4,418,000 6,104,000 19,058,000
Operating Income/Loss -4,051,000 -4,154,000 -5,795,000 -17,974,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 8,488,000 63,000 724,000 9,325,000
Preferred Stock Dividends And Other Adjustments 8,488,000 63,000 724,000 9,325,000
Revenues 212,000 264,000 309,000 1,084,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-04-01
Assets UNPUB UNPUB UNPUB 19,354,000
Current Assets UNPUB UNPUB UNPUB 18,872,000
Current Liabilities UNPUB UNPUB UNPUB 9,335,000
Equity UNPUB UNPUB UNPUB 10,019,000
Equity Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Equity Attributable To Parent UNPUB UNPUB UNPUB 10,019,000
Liabilities UNPUB UNPUB UNPUB 9,335,000
Liabilities And Equity UNPUB UNPUB UNPUB 19,354,000
Noncurrent Assets UNPUB UNPUB UNPUB 482,000
Noncurrent Liabilities UNPUB UNPUB UNPUB 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-04-01
Exchange Gains/Losses UNPUB UNPUB UNPUB -19,000
Net Cash Flow UNPUB UNPUB UNPUB -8,056,000
Net Cash Flow, Continuing UNPUB UNPUB UNPUB -8,037,000
Net Cash Flow From Financing Activities UNPUB UNPUB UNPUB 3,975,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB UNPUB 3,975,000
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB 50,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB 50,000
Net Cash Flow From Operating Activities UNPUB UNPUB UNPUB -12,043,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB UNPUB -12,043,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-04-01
Comprehensive Income/Loss UNPUB UNPUB UNPUB -13,186,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -13,186,000
Other Comprehensive Income/Loss UNPUB UNPUB UNPUB 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -13,195,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-04-01
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB 15,176,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB 15,172,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB UNPUB UNPUB -13,756,000
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB UNPUB -15,107,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB -1,351,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss UNPUB UNPUB UNPUB -13,186,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Net Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -13,186,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB UNPUB -13,914,000
Operating Expenses UNPUB UNPUB UNPUB 15,172,000
Operating Income/Loss UNPUB UNPUB UNPUB -15,103,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB UNPUB 728,000
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB UNPUB 728,000
Revenues UNPUB UNPUB UNPUB 69,000
Calendar
19 May 2024 (Time UTC) Actual Previous Consensus
★★★
15:30
United States
17 May 2024 (Time UTC) Actual Previous Consensus
★
15:30
United States
-17800.000
★
15:30
United States
-60000.000
★
15:30
United States
53700.000
★
15:30
United States
-135800.000
★★
15:30
United States
4400.000
★
15:30
United States
215400.000
★
15:30
United States
-31400.000
★
15:30
United States
62600.000
★
15:30
United States
1300.000
★
15:30
United States
-9700.000
★
15:30
United States
199600.000
★★
15:30
United States
★
15:30
United States
★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:CYCC240517P00007500 OPASPS Put American 100 7.5 EMLD 2024-05-17
O:CYCC240517P00005000 OPASPS Put American 100 5 EMLD 2024-05-17
O:CYCC240517P00002500 OPASPS Put American 100 2.5 EMLD 2024-05-17
O:CYCC240517C00007500 OCASPS Call American 100 7.5 EMLD 2024-05-17
O:CYCC240517C00005000 OCASPS Call American 100 5 EMLD 2024-05-17
O:CYCC240517C00002500 OCASPS Call American 100 2.5 EMLD 2024-05-17
O:CYCC1240517P00002500 OPASPN Put American 6 2.5 XASE 2024-05-17
O:CYCC1240517C00002500 OCASPN Call American 6 2.5 XASE 2024-05-17
O:CYCC1240216P00007500 OPASPN Put American 6 7.5 XASE 2024-02-16
O:CYCC1240216P00002500 OPASPN Put American 6 2.5 XASE 2024-02-16
O:CYCC1240216C00007500 OCASPN Call American 6 7.5 XASE 2024-02-16
O:CYCC1240216C00002500 OCASPN Call American 6 2.5 XASE 2024-02-16
O:CYCC240216P00007500 OPASPS Put American 100 7.5 EMLD 2024-02-16
O:CYCC240216P00005000 OPASPS Put American 100 5 EMLD 2024-02-16
O:CYCC240216P00002500 OPASPS Put American 100 2.5 EMLD 2024-02-16
O:CYCC240216C00007500 OCASPS Call American 100 7.5 EMLD 2024-02-16
O:CYCC240216C00005000 OCASPS Call American 100 5 EMLD 2024-02-16
O:CYCC240216C00002500 OCASPS Call American 100 2.5 EMLD 2024-02-16
O:CYCC240119P00007500 OPASPS Put American 100 7.5 EMLD 2024-01-19
O:CYCC240119P00005000 OPASPS Put American 100 5 EMLD 2024-01-19
O:CYCC240119P00002500 OPASPS Put American 100 2.5 EMLD 2024-01-19
O:CYCC240119C00007500 OCASPS Call American 100 7.5 EMLD 2024-01-19
O:CYCC240119C00005000 OCASPS Call American 100 5 EMLD 2024-01-19
O:CYCC240119C00002500 OCASPS Call American 100 2.5 EMLD 2024-01-19
O:CYCC231215P00007500 OPASPS Put American 100 7.5 EMLD 2023-12-15
O:CYCC231215P00005000 OPASPS Put American 100 5 EMLD 2023-12-15
O:CYCC231215P00002500 OPASPS Put American 100 2.5 EMLD 2023-12-15
O:CYCC231215C00007500 OCASPS Call American 100 7.5 EMLD 2023-12-15
O:CYCC231215C00005000 OCASPS Call American 100 5 EMLD 2023-12-15
O:CYCC231215C00002500 OCASPS Call American 100 2.5 EMLD 2023-12-15
O:CYCC231117P00007500 OPASPS Put American 100 7.5 EMLD 2023-11-17
O:CYCC231117P00005000 OPASPS Put American 100 5 EMLD 2023-11-17
O:CYCC231117P00002500 OPASPS Put American 100 2.5 EMLD 2023-11-17
O:CYCC231117C00007500 OCASPS Call American 100 7.5 EMLD 2023-11-17
O:CYCC231117C00005000 OCASPS Call American 100 5 EMLD 2023-11-17
O:CYCC231117C00002500 OCASPS Call American 100 2.5 EMLD 2023-11-17
O:CYCC231020P00007500 OPASPS Put American 100 7.5 EMLD 2023-10-20
O:CYCC231020P00005000 OPASPS Put American 100 5 EMLD 2023-10-20
O:CYCC231020P00002500 OPASPS Put American 100 2.5 EMLD 2023-10-20
O:CYCC231020C00007500 OCASPS Call American 100 7.5 EMLD 2023-10-20
O:CYCC231020C00005000 OCASPS Call American 100 5 EMLD 2023-10-20
O:CYCC231020C00002500 OCASPS Call American 100 2.5 EMLD 2023-10-20
O:CYCC230915P00007500 OPASPS Put American 100 7.5 EMLD 2023-09-15
O:CYCC230915P00005000 OPASPS Put American 100 5 EMLD 2023-09-15
O:CYCC230915P00002500 OPASPS Put American 100 2.5 EMLD 2023-09-15
O:CYCC230915C00007500 OCASPS Call American 100 7.5 EMLD 2023-09-15
O:CYCC230915C00005000 OCASPS Call American 100 5 EMLD 2023-09-15
O:CYCC230915C00002500 OCASPS Call American 100 2.5 EMLD 2023-09-15
O:CYCC230818P00007500 OPASPS Put American 100 7.5 EMLD 2023-08-18
O:CYCC230818P00005000 OPASPS Put American 100 5 EMLD 2023-08-18
O:CYCC230818P00002500 OPASPS Put American 100 2.5 EMLD 2023-08-18
O:CYCC230818C00007500 OCASPS Call American 100 7.5 EMLD 2023-08-18
O:CYCC230818C00005000 OCASPS Call American 100 5 EMLD 2023-08-18
O:CYCC230818C00002500 OCASPS Call American 100 2.5 EMLD 2023-08-18
News Stream
Calendar Calendar of Events
Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results
BERKELEY HEIGHTS, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce first quarter 2024 financial results on Tuesday, May 14, 2024. The Company will host a conference call and live webcast at 4:30 p.m. Eastern Daylight Time on the same day.
GlobeNewswire Inc. • 1w ago
Stocks Stock Market News
Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules
BERKELEY HEIGHTS, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that it has closed its previously announced private placement for the purchase and sale of 4,968,945 shares of common stock (or pre-funded warrants in lieu thereof), series A warrants to purchase up to 4,968,945 shares of common stock and short-term series B warrants to purchase up to 4,968,945 shares of common stock at a purchase price of $1.61 per share of common stock (or per pre-funded warrant in lieu thereof) and accompanying warrants priced at-the-market under Nasdaq rules. The series A warrants and short-term series B warrants have an exercise price of $1.36 per share and are exercisable immediately upon issuance. The series A warrants expire five and one-half years from the date of issuance and the short-term series B warrants expire eighteen months from the date of issuance.
GlobeNewswire Inc. • 2w ago
Stocks Financing Agreements
Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
BERKELEY HEIGHTS, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 4,968,945 shares of common stock (or pre-funded warrant in lieu thereof), series A warrants to purchase up to 4,968,945 shares of common stock and short-term series B warrants to purchase up to 4,968,945 shares of common stock at a purchase price of $1.61 per share of common stock (or per pre-funded warrant in lieu thereof) and accompanying warrants in a private placement priced at-the-market under Nasdaq rules. The series A warrants and short-term series B warrants will have an exercise price of $1.36 per share and will be exercisable immediately upon issuance. The series A warrants will expire five and one-half years from the date of issuance and the short-term series B warrants will expire eighteen months from the date of issuance. The private placement is expected to close on or about May 2, 2024, subject to the satisfaction of customary closing conditions.
GlobeNewswire Inc. • 2w ago
News Clinical Study
Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer
- New clinical, PK and PD data from novel CDK2/9 inhibitor fadraciclib monotherapy studies support ongoing development program in patients with solid tumors and lymphoma -
GlobeNewswire Inc. • 1mo ago
Stocks Earnings Releases and Operating Results
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
– On Track to Start Oral Fadraciclib Phase 2 Proof of Concept in 1H 2024 –
GlobeNewswire Inc. • 2mo ago
Calendar Calendar of Events
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results
BERKELEY HEIGHTS, N.J., March 13, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce fourth quarter and full year 2023 financial results on Tuesday, March 19, 2024. The Company will host a conference call at 4:30pm ET on the same day.
GlobeNewswire Inc. • 2mo ago
Calendar Calendar of Events
Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
Data support ongoing development program of novel CDK2/9 inhibitor fadraciclib in patients with solid tumors and lymphoma Data support ongoing development program of novel CDK2/9 inhibitor fadraciclib in patients with solid tumors and lymphoma
GlobeNewswire Inc. • 2mo ago
Stocks Tax Issues/Accounting
Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit
BERKELEY HEIGHTS, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, announced that it received £2.3 million (approximately $2.9 million) as a research & development (R&D) tax credit from HMRC, the tax agency of the United Kingdom government. The tax credit is based on R&D costs incurred in the year ended December 31, 2023. The Company expects to receive an additional approximately $0.8 million following confirmation of a change in the rate of tax credit regarding 2023 expenditures.
GlobeNewswire Inc. • 2mo ago
Stocks Company Announcement
Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference
BERKELEY HEIGHTS, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that Spiro Rombotis, President and Chief Executive Officer, is scheduled to present at the 2024 BIO CEO & Investor Conference taking place in-person at the New York Marriott Marquis on February 26-27, 2024.
GlobeNewswire Inc. • 2mo ago
Management Directors and Officers
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer
BERKELEY HEIGHTS, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, announced today that Brian Schwartz, M.D. will assume the role of interim Chief Medical Officer (“CMO”) of the Company effective immediately. Dr. Schwartz will succeed Mark Kirschbaum, M.D., whose employment was terminated by the Company.
GlobeNewswire Inc. • 3mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT